Onconetix, Inc. Warrant Down Round Feature Increase Decrease In Equity Amount1
Onconetix, Inc. (ONCO) reported Warrant Down Round Feature Increase Decrease In Equity Amount1 of $2.546 for the 1-month period ending 2023-07-31, per its 10-Q filed 2023-11-17.
Discontinued › Shareholders' Equity
us-gaap:WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1 · last filed 2023-11-17
- 2023-07-31: Warrant Down Round Feature Increase Decrease In Equity Amount1 1 month $2.55.
| Period end | Warrant Down Round Feature Increase Decrease In Equity Amount1 1 month |
|---|---|
| 2023-07-31 | $2.55 10-Q · filed 2023-11-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |